TCP
BSX icon

Tourbillon Capital Partners’s Boston Scientific BSX Stock Holding History

Tourbillon Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-165,200
Closed -$4.09M – 59
2017
Q4 		$4.09M Buy
+165,200
New +$4.56M 0.15% 43

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Tourbillon Capital Partners's BSX Position: Q1 2018 in Review

Tourbillon Capital Partners sold out of Boston Scientific (BSX) in Q1 2018, closing a stake of 450,000 shares — an estimated $11.2M sold.

Tourbillon Capital Partners first reported a position in BSX in Q4 2017 and held it in 1 quarter. The position peaked at $11.2M in Q4 2017. 634 funds tracked by Wall St. Rank hold BSX as of Q1 2018.

  • Tourbillon Capital Partners reported no remaining Boston Scientific position as of Q1 2018 after selling out during the quarter.
  • Tourbillon Capital Partners sold 450,000 Boston Scientific shares in Q1 2018, an estimated $11.2M.
  • Tourbillon Capital Partners first reported a position in Boston Scientific in Q4 2017 and held it in 1 quarter.
  • Tourbillon Capital Partners's Boston Scientific position peaked at $11.2M in Q4 2017.
  • 634 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2018.

Based on Tourbillon Capital Partners's 13F filing for Q1 2018, filed 15 May 2018.